| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/06/2006 | EP1698701A1 Use of MHC class II ligands as adjuvant for vaccination and lag-3 in cancer treatment |
| 09/06/2006 | EP1698697A2 SSD-containing protein, process for producing the same and use thereof |
| 09/06/2006 | EP1698639A2 Pluripotency determining factors and uses thereof |
| 09/06/2006 | EP1698638A1 Lipopeptides having pharmaceutical activity |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698623A1 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/06/2006 | EP1698346A1 Agent against malignant neuroglia and agent against malignant neuroglia for animals |
| 09/06/2006 | EP1698345A2 Peptide antagonists of zonulin and methods for use of the same |
| 09/06/2006 | EP1698340A1 T-type calcium channel inhibitor |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1697529A1 Viral particles containing an alpha virus derived vector and method for preparing said viral particle |
| 09/06/2006 | EP1697421A2 Bispecific antibodies |
| 09/06/2006 | EP1697417A2 Antibodies against secretory leukocyte protease inhibitor |
| 09/06/2006 | EP1697397A1 Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation |
| 09/06/2006 | EP1697392A1 Glycosylated triketide delta lactones |
| 09/06/2006 | EP1697384A1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 09/06/2006 | EP1697381A1 Mitotic kinesin inhibitors |
| 09/06/2006 | EP1697375A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 09/06/2006 | EP1697356A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
| 09/06/2006 | EP1697354A1 Isothiazole dioxides as cxc- and cc- chemokine receptor ligands |
| 09/06/2006 | EP1697331A2 Mitotic kinesin inhibitors |
| 09/06/2006 | EP1697318A1 Prolinylarylacetamides |
| 09/06/2006 | EP1696957A2 Radiation therapy and medical imaging using uv emitting nanoparticles |
| 09/06/2006 | EP1696950A2 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 09/06/2006 | EP1696917A1 COMBINATION OF (a) N-{5- [4-(4-METHYL-PIPERAZINO-METHYL) -BENZOYLAMIDO] -2METHYLPHENYL]-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE AND (b) AT LEAST ONE HYPUSINATION INHIBITOR AND THE USE THEREOF |
| 09/06/2006 | EP1696914A1 3-cyano-quinoline derivatives with antiproliferative activity |
| 09/06/2006 | EP1696913A1 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 09/06/2006 | EP1696907A1 Pdk-1/akt signaling inhibitors |
| 09/06/2006 | EP1696898A2 Zn 24 -chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors |
| 09/06/2006 | EP1551378A4 Epo d + 5-fu/gemcitabine |
| 09/06/2006 | EP1525215B1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 09/06/2006 | EP1458697B1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1385513B1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1253909B1 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 09/06/2006 | EP1204418B1 Compositions containing muscle-derived active agents |
| 09/06/2006 | EP1176964B1 Uses of et743 for treating cancer |
| 09/06/2006 | EP1173224B1 Polyethyleneimine:dna formulations for aerosol delivery |
| 09/06/2006 | EP1135374B1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/06/2006 | EP1014990B1 Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum |
| 09/06/2006 | EP0914341B1 Antagonists of intestinotrophic glp-2 peptides |
| 09/06/2006 | EP0815204B1 Method for treating tumors by alloactivated human donor lymphocytes |
| 09/06/2006 | CN1829741A Treatment with anti-VEGF antibodies |
| 09/06/2006 | CN1829740A Connective tissue growth factor antibodies |
| 09/06/2006 | CN1829713A 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
| 09/06/2006 | CN1829523A Viral vectors |
| 09/06/2006 | CN1829514A CCI-779 lyophilized formulations |
| 09/06/2006 | CN1829506A Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 09/06/2006 | CN1827649A Fusion toxin protein and uses thereof |
| 09/06/2006 | CN1827640A Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 09/06/2006 | CN1827635A Glycopeptide compositions |
| 09/06/2006 | CN1827629A Glucose phosphonic amide crystals and preparation process and use thereof |
| 09/06/2006 | CN1827604A Nitro compounds and their application in preparation of pemetrexed |
| 09/06/2006 | CN1827603A Novel pyrazole analogs acting on cannabinoid receptors |
| 09/06/2006 | CN1827578A Anti-tumor naphthoquinone formic acid soft analogues |
| 09/06/2006 | CN1827140A Chinese medicinal pill for treating cancer |
| 09/06/2006 | CN1827118A Method for preparing nanometer realgar gel and nanometer realgar with biomacromolecule template to regulate shape and particle thereof |
| 09/06/2006 | CN1827108A Use of cytosine derivative for preparing drug for treating cancer |
| 09/06/2006 | CN1827096A Docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method thereof |
| 09/06/2006 | CN1827091A Medicinal composition containing backuchiol for treating female breast cancer |
| 09/06/2006 | CN1827090A Medicinal composition containing backuchiol for treating female osteoporosis |
| 09/06/2006 | CN1826922A Preparation and process for instant soluble tea with fiveleaf gynostemma herb |
| 09/06/2006 | CN1826917A Health drink with milk and snow lotus live body and preparation method |
| 09/06/2006 | CN1273599C Thioredoxin peroxidase gene of China Qingdao branchiostoma and use thereof |
| 09/06/2006 | CN1273587C Herpesvirus thymine deoxyriboside kinase mutant and use thereof |
| 09/06/2006 | CN1273586C Novel 'beta'-l-4N-acetylglucosaminyltransferase and gene encoding the same |
| 09/06/2006 | CN1273496C Polysaccharose MF4 of mussel with enhancing immunity and anti-tumour activity |
| 09/06/2006 | CN1273495C Anti-tumor activating fuling scloerotium glucan sulfate and its preparation and use |
| 09/06/2006 | CN1273492C Polysaccharide, preparation and use thereof |
| 09/06/2006 | CN1273489C Monoclone antibody against HnRNP A2/B1 antigen, its preparation and use |
| 09/06/2006 | CN1273478C Novel nucleosides and oligonucleotide analogues |
| 09/06/2006 | CN1273476C Oligonucleotide analoguse |
| 09/06/2006 | CN1273470C Polycyclic xanthones as antibiotics |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273456C Thiazole or oxazole derivatives |
| 09/06/2006 | CN1273454C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273195C Carbonized pollen and its application in preparation of cancer-treating medicine |
| 09/06/2006 | CN1273192C Method and composition for altering a T cell mediated pathology |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273183C Method for extracting effective constituent from Sand Ginger by bi-enzyme method |
| 09/06/2006 | CN1273146C Composition for treating tumor |
| 09/06/2006 | CN1273141C Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate and preparation method thereof |
| 09/06/2006 | CN1273130C Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 09/06/2006 | CN1273123C Application of (3R,4R)-delta 8-tetrahydrocannabinol)-11-acid in preparation of medicine for reducing cell proliferation |
| 09/06/2006 | CN1273114C Sichuan aconite root freeze-dried powder injection and its preparing method |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/05/2006 | USRE39267 Thienopyrimidine-based inhibitors of the SRC family |
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |